(Q38467184)

English

HDL cholesterol and residual risk of first cardiovascular events after treatment with potent statin therapy: an analysis from the JUPITER trial

scientific article published on 23 July 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

HDL cholesterol and residual risk of first cardiovascular events after treatment with potent statin therapy: an analysis from the JUPITER trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

1 reference

based on heuristic

inferred from title

Børge G. Nordestgaard

6

object named as

Børge G Nordestgaard

0 references

4

object named as

Peter Libby

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

1

object named as

Paul M Ridker

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

9

object named as

Robert J Glynn

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

John J. P. Kastelein

10

object named as

John J P Kastelein

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Jacques Genest jr.

2

object named as

Jacques Genest

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Jean G MacFadyen

8

object named as

Jean G MacFadyen

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

JUPITER Trial Study Group

11

object named as

JUPITER Trial Study Group

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

7

object named as

Samia Mora

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

S Matthijs Boekholdt

3

object named as

S Matthijs Boekholdt

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

author name string

Antonio M Gotto

5

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

language of work or name

0 references

publication date

23 July 2010

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

number of pages

7

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

376

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

9738

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

333-339

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960713-1

7 January 2021

based on heuristic

inferred from DOI database lookup

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960713-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960713-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960713-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960713-1

7 January 2021

based on heuristic

inferred from DOI database lookup

High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960713-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Serum lipids and incidence of coronary heart disease. Findings from the Systolic Hypertension in the Elderly Program (SHEP).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960713-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Triglycerides and HDL-cholesterol as risk factors for ischemic heart disease. Results from the Québec cardiovascular study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960713-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: The Atherosclerosis Risk in Communities (ARIC) Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960713-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960713-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical significance of high-density lipoprotein cholesterol in patients with low low-density lipoprotein cholesterol

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960713-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of pravastatin on coronary disease events in subgroups defined by coronary risk factors: the Prospective Pravastatin Pooling Project

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960713-1

7 January 2021

based on heuristic

inferred from DOI database lookup

HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960713-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic utility of apoB/AI, total cholesterol/HDL, non-HDL cholesterol, or hs-CRP as predictors of clinical risk in patients receiving statin therapy after acute coronary syndromes: results from PROVE IT-TIMI 22.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960713-1

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized trial of rosuvastatin in the prevention of venous thromboembolism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960713-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960713-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Relation between baseline and on-treatment lipid parameters and first acute major coronary events in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960713-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Metabolic and physiologic improvements from consuming a paleolithic, hunter-gatherer type diet

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960713-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Beyond high-density lipoprotein cholesterol levels evaluating high-density lipoprotein function as influenced by novel therapeutic approaches

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960713-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of torcetrapib in patients at high risk for coronary events

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960713-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of torcetrapib on the progression of coronary atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960713-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of torcetrapib on carotid atherosclerosis in familial hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960713-1

7 January 2021

based on heuristic

inferred from DOI database lookup

The failure of torcetrapib: was it the molecule or the mechanism?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960713-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Association between change in high density lipoprotein cholesterol and cardiovascular disease morbidity and mortality: systematic review and meta-regression analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960713-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(10)60713-1

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38467184&oldid=2118777229"